| Code | CSB-RA937256A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:5000 |
| IHC | 1:50-1:200 |
| IF | 1:50-1:200 |
| FC | 1:50-1:200 |
Carbonyl reductase 1 (CBR1) serves as a critical metabolic enzyme with dual significance in biomedical research. This NADPH-dependent oxidoreductase catalyzes the reduction of various carbonyl compounds, including prostaglandins and xenobiotic substrates, positioning it at the intersection of endogenous metabolism and drug biotransformation. CBR1's role in metabolizing anthracycline chemotherapeutics has made it particularly relevant to cancer pharmacology research, while its involvement in prostaglandin E2 metabolism connects it to inflammatory signaling pathways.
This recombinant monoclonal antibody, generated against a synthetic peptide from human CBR1, offers the reproducibility that demanding experimental workflows require. As a sequence-defined reagent produced through recombinant technology, it eliminates the lot-to-lot variability that can compromise longitudinal studies or multi-site collaborations. The rabbit IgG format, purified by affinity chromatography, ensures consistent performance across your research timeline.
Validation data demonstrates robust performance across multiple detection platforms. Western blot analysis in A549 and A431 whole cell lysates reveals a band at approximately 35 kDa, slightly higher than the predicted 30 kDa molecular weight—a shift likely attributable to post-translational modifications such as glycosylation or phosphorylation events. Immunohistochemistry staining in human small intestine tissue confirms utility for tissue-based studies, while immunofluorescence in HeLa cells and flow cytometry analysis in A431 cells extend its application to single-cell resolution techniques.
This versatility across western blotting, immunohistochemistry, immunofluorescence, and flow cytometry provides researchers investigating signal transduction pathways with a single reliable reagent for orthogonal validation approaches, streamlining experimental design while maintaining scientific rigor.
There are currently no reviews for this product.